Thank you
Thank you for attending today's virtual seminar. We hope you enjoyed our event.
Contributors
-
Laura Boullon, PhD candidate, National University of Ireland Galway, Ireland
Laura Boullon obtained her bachelor's degree in biology with specialization in medical biology from Universidad Complutense de Madrid, Spain, in 2017. Laura is currently a doctoral candidate in the Department of Pharmacology and Therapeutics, National University of Ireland Galway, under the supervision of Dr. Alvaro-Llorente Berzal and Professor David Finn. Her research interests include neuroscience, sexual dimorphism, the endocannabinoid system, and neuropathic pain.
-
Alexander Davies, PhD, University of Oxford, UK
Dr. Davies completed his PhD training in the neurophysiology of the trigeminal brainstem with Professor R. Alan North at the University of Manchester, UK. During postdoctoral training with Professor Seog Bae Oh at Seoul National University in South Korea his research moved into the spinal mechanisms of neuropathic pain and dental pain focusing on the archetypal nociceptor TRPV1. Subsequently, as an NRF Junior Research Fellow, he led a team of international collaborators to reveal a novel mechanism of immune-mediated axon degeneration after peripheral nerve injury by cytotoxic ‘killer’ cells. Now a Research Fellow at the University of Oxford, he leads an investigation into the molecular mechanisms of cellular cytotoxicity in immune-mediated recovery from nerve injury, as well as developing novel methods to study human neuro-immune interactions in vitro.
-
Oliver Sandy-Hindmarch, PhD, University of Oxford, UK
Oliver Sandy-Hindmarch is a post-doctoral researcher at the Nuffield Department of Clinical Neurosciences at the University of Oxford. He earned his undergraduate degree in biochemistry from the University of Portsmouth, followed by an MSc in pharmaceutical sciences at the University of Nottingham and a DPhil in clinical neurosciences at the University of Oxford. His work focuses on investigating the role that the immune system and inflammation play in the initiation, maintenance, and resolution of neuropathic pain. Specifically, he is interested in the role that certain immune cell types, such as T cells or macrophages, have in neuropathic pain. To study this, Oliver combines data from biological samples of patients with peripheral neuropathies with detailed clinical phenotypic data.
-
Patrick Dougherty, PhD, The University of Texas MD Anderson Cancer Center, US
Patrick Dougherty, PhD, is the H.E.B. Professor in Cancer Research and Associate Division Head for Research in the Department of Pain Medicine, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX. His recent work has centered on determining the mechanisms of neuropathic pain experienced by cancer patients. The work has been composed of parallel studies conducted in both humans and animals. In the human studies, his group has conducted psychophysical studies to define the sensory fibers involved in these pain conditions and, more recently, expanded this work to utilize human dorsal root ganglia tissue excised during surgical treatment for cancer. The animal studies seek to define both the peripheral and central neurophysiological mechanisms that are altered following cancer and cancer chemotherapy and to determine agents that may provide a neuroprotective role. The current emphasis in each of these studies is to determine the role that innate immune mechanisms play in the pathogenesis of cancer- and cancer treatment-evoked neuropathic pain.